Phibro Animal Health Co. (NASDAQ:PAHC) Short Interest Update

Phibro Animal Health Co. (NASDAQ:PAHC) was the target of a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 726,000 shares, a drop of 23.1% from the February 28th total of 943,800 shares. Approximately 3.6% of the company’s shares are short sold. Based on an average trading volume of 249,900 shares, the short-interest ratio is currently 2.9 days.

Phibro Animal Health Stock Up 2.9 %

PAHC stock traded up $0.61 on Tuesday, reaching $21.97. 272,377 shares of the company traded hands, compared to its average volume of 184,441. The firm has a fifty day simple moving average of $22.79 and a 200-day simple moving average of $22.69. The company has a market cap of $889.85 million, a P/E ratio of 45.77, a price-to-earnings-growth ratio of 0.45 and a beta of 0.58. Phibro Animal Health has a one year low of $12.17 and a one year high of $26.55. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Research analysts anticipate that Phibro Animal Health will post 1.95 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th were paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 2.18%. The ex-dividend date of this dividend was Wednesday, March 5th. Phibro Animal Health’s dividend payout ratio is currently 100.00%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. Barclays upped their price objective on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research note on Monday, February 10th. Morgan Stanley increased their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Finally, StockNews.com cut Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Tuesday, March 25th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $21.00.

Institutional Trading of Phibro Animal Health

Institutional investors have recently made changes to their positions in the stock. Thrivent Financial for Lutherans lifted its position in Phibro Animal Health by 23.1% during the third quarter. Thrivent Financial for Lutherans now owns 20,791 shares of the company’s stock valued at $468,000 after purchasing an additional 3,907 shares during the period. FMR LLC raised its stake in Phibro Animal Health by 22.7% during the 3rd quarter. FMR LLC now owns 39,310 shares of the company’s stock worth $885,000 after acquiring an additional 7,270 shares during the period. Quantbot Technologies LP purchased a new position in Phibro Animal Health during the third quarter valued at approximately $70,000. BNP Paribas Financial Markets increased its stake in shares of Phibro Animal Health by 3.1% in the third quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock worth $548,000 after purchasing an additional 729 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. boosted its stake in shares of Phibro Animal Health by 116.6% in the third quarter. Jacobs Levy Equity Management Inc. now owns 192,255 shares of the company’s stock worth $4,330,000 after acquiring an additional 103,491 shares during the period. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.